Diabetes treatment is constantly progressing, with new therapeutic options developing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://gretajnhd868088.law-wiki.com/2013216/novel_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment